Eli Lilly's most recent trend suggests a bearish bias. One trading opportunity on Eli Lilly is a Bear Call Spread using a strike $68.50 short call and a strike $73.50 long call offers a potential 11.86% return on risk over the next 11 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $68.50 by expiration. The full premium credit of $0.53 would be kept by the premium seller. The risk of $4.47 would be incurred if the stock rose above the $73.50 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Eli Lilly is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Eli Lilly is bearish.
The RSI indicator is at 22.05 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Eli Lilly
[$$] Prevention of Alzheimer's is the way forward
Sun, 04 Dec 2016 22:45:16 GMT
Financial Times – Sir, For a small fraction of the $3bn spent by Eli Lilly on anti-amyloid drug development (“Symptoms of failure”, The Big Read, December 1), a trial could be done on a preventive intervention …
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Sun, 04 Dec 2016 18:04:17 GMT
Why Eli Lilly Shares Lost 8% in November
Sat, 03 Dec 2016 13:04:03 GMT
Lilly Could Pocket $1.7 Billion In Fresh Diabetes Drug Sales In 2025
Fri, 02 Dec 2016 21:35:39 GMT
Lilly Spikes on FDA Jardiance Approval (LLY)
Fri, 02 Dec 2016 20:30:00 GMT
Also on Market Tamer…
Follow Us on Facebook